Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-23-011932
Filing Date
2023-05-01
Accepted
2023-05-01 16:49:38
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A ctdh20221231_10ka.htm   iXBRL 10-K/A 248997
2 EXHIBIT 31.1 ex_510651.htm EX-31.1 3963
3 EXHIBIT 31.2 ex_510646.htm EX-31.2 3973
  Complete submission text file 0001437749-23-011932.txt   502429

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20221231.xsd EX-101.SCH 4076
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20221231_def.xml EX-101.DEF 19199
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20221231_lab.xml EX-101.LAB 25649
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20221231_pre.xml EX-101.PRE 19991
9 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20221231_10ka_htm.xml XML 7657
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

EIN.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39780 | Film No.: 23874571
SIC: 2836 Biological Products, (No Diagnostic Substances)